| Name | Title | Contact Details |
|---|
Alternative Resources Company is a Valhalla, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Indiana Regional Medical Center is the only regional hospital that offers a dedicated Center for Wound Healing to help heal chronic wounds as well as Hyperbaric Oxygen Therapy for non-healing wounds.
Berks Community Health Center is a freestanding, non-profit Federally Qualified Health Center, providing patient-centered, affordable, high-quality primary health care.
Tennessee Heart and Vascular is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hendersonville, TN. To find more information about Tennessee Heart and Vascular, please visit www.tennheart.com
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.